| Announce Date | 11/24/2025 |
| EPS Normalized Actual | $-0.09 (Beat by $0.11) |
| EPS GAAP Actual | $-0.09 (Beat by $0.11) |
| Revenue Actual | $0.617373B |
| Revenue Surprise | Beat by $617.373M |
| Announce Date | 03/27/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.00667 |
| EPS GAAP Estimate | $1.00667 |
| Revenue Estimate | $0.9084979B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Sep 2030 | 3.98 | 9.55 | 3.93428 | 4.02466 | 1 |
| Sep 2029 | 3.58 | 10.61 | 3.52758 | 3.66326 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.11 | -0.03 | 0.617373B | -6.33% | -14.53M |
| FQ3 2025 (Sep 2025) | -0.16 | -0.035 | 0.678178B | 1.28% | -11.52M |
| FQ2 2025 (Jun 2025) | 1.51 | 1.51 | 0.960913B | -3.69% | 960.91M |
| FQ1 2025 (Mar 2025) | 0.99 | 0.99 | 0.833537B | -7.98% | 833.54M |
| FQ4 2024 (Dec 2024) | 0.22 | 0.22 | 0.656436B | 3.34% | 656.44M |
| FQ3 2024 (Sep 2024) | -0.52 | -0.52 | 0.669489B | -12.05% | 669.49M |
| FQ2 2024 (Jun 2024) | 1.21 | 1.21 | 0.996348B | -2.7% | 996.35M |
| FQ1 2024 (Mar 2024) | 0.94 | 0.94 | 0.90009B | 100% | 900.09M |
FQ4 Announce Date
03/27/2026 (Pre-Market)
Consensus EPS Estimates
1.00667
Consensus Revenue Estimates
0.9084979B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (Jun 2027) | 1.675 | -- | 1.65364 | 1.70137 | 1 |
| FQ1 2027 (Mar 2027) | 1.135 | -- | 1.12052 | 1.15287 | 1 |
| FQ4 2026 (Dec 2026) | 0.135 | 18.52 | 0.13328 | 0.13713 | 1 |
| FQ3 2026 (Sep 2026) | -0.1 | -60 | -0.10121 | -0.09815124 | 2 |
| FQ2 2026 (Jun 2026) | 1.4 | -7.86 | 1.37412 | 1.41697 | 2 |
| FQ1 2026 (Mar 2026) | 1.00667 | 1.66 | 0.98806 | 1.01887 | 2 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (Jun 2027) | 1.02B | -- | 1.01B | 1.04B | 2 |
| FQ1 2027 (Mar 2027) | 0.88B | -- | 0.87B | 0.89B | 2 |
| FQ4 2026 (Dec 2026) | 0.65B | 4.51 | 0.64B | 0.65B | 1 |
| FQ3 2026 (Sep 2026) | 0.72B | 5.83 | 0.71B | 0.73B | 3 |
| FQ2 2026 (Jun 2026) | 1.05B | 8.05 | 1.03B | 1.05B | 3 |
| FQ1 2026 (Mar 2026) | 0.91B | 8.25 | 0.9B | 0.92B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.14 | 0.11 | -0.03 | -27.27% |
| FQ3 2025 (Sep 2025) | -0.125 | -0.16 | -0.035 | 21.88% |
| FQ2 2025 (Jun 2025) | 1.51 | 1.51 | 100% | |
| FQ1 2025 (Mar 2025) | 0.99 | 0.99 | 100% | |
| FQ4 2024 (Dec 2024) | 0.22 | 0.22 | 100% | |
| FQ3 2024 (Sep 2024) | -0.52 | -0.52 | 100% | |
| FQ2 2024 (Jun 2024) | 1.21 | 1.21 | 100% | |
| FQ1 2024 (Mar 2024) | 0.94 | 0.94 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0.63B | $0.62B | $-14.53M | -2.35% |
| FQ3 2025 (Sep 2025) | $0.69B | $0.68B | $-11.52M | -1.7% |
| FQ2 2025 (Jun 2025) | $0B | $0.96B | $960.91M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.83B | $833.54M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.66B | $656.44M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.67B | $669.49M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1B | $996.35M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.9B | $900.09M | 100% |